EPH Receptor A4 anticorps (Extracellular, N-Term)
Aperçu rapide pour EPH Receptor A4 anticorps (Extracellular, N-Term) (ABIN7043124)
Antigène
Voir toutes EPH Receptor A4 (EPHA4) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 485-499, Extracellular, N-Term
-
Fonction
- A Rabbit Polyclonal antibody to EphA4 (extracellular).
-
Réactivité croisée
- Humain, Souris, Rat
-
Homologie
- Mouse,rat - identical
-
Attributs du produit
- A rabbit polyclonal antibody to EphA4 (extracellular).
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogène
- (C)ERSYRIVRTAARNTD, corresponding to amino acid residues 485 - 499 of human EPHA4
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:200
FC: 2.5 μg per reaction
ICC: The optimal concentration should be determined by the user
IHC: The optimal concentration should be determined by the user
IP: The optimal concentration should be determined by the user
-
Commentaires
-
Negative Control: (ABIN7235286)
Blocking Peptide: (ABIN7235286)
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- 25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.
-
Concentration
- 0.8 mg/mL
-
Buffer
- PBS pH 7.4, 1 % BSA with 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
-
-
- EPH Receptor A4 (EPHA4)
-
Autre désignation
- EPHA4
-
Sujet
-
Synonyms: Ephrin Type-A Receptor 4, EPH-Like Kinase 8, EPHA4
Description: EphA4 is a member of the Eph receptor tyrosine kinase family.Eph receptors are subdivided into two subclasses, termed EphA and EphB, based on sequence similarity and their preference for binding a particular subclass of ephrins. The domain organization of Eph receptors contains a globular ligand binding domain (LBD), a cysteine-rich region, and two fibronectin type III domains (FN1 and FN2). It also contains a transmembrane (TM) helix, and an intracellular part consisting of a juxtamembrane (JM) region and a tyrosine kinase domain. Eph kinase activity is auto-inhibited through interaction with its own JM region, this auto inhibition is released by phosphorylation1.Interactions of Eph receptors with their ligands, ephrins, at cell-cell interfaces promote a variety of cellular responses, including repulsion, attraction and migration2.EphA4 is activated by all members of the ephrin-A ligand family and most members of the ephrin-B family1. Upon ligand binding it activates pathways that regulate the formation of the axon tract and cortical network as well as radial migration of cortical neurons in the cortex3.EphA4 is expressed in the neural ectoderm at embryonic day 8 and then in various cell types throughout the cortex during subsequent stages of neurodevelopment4, its major effect on cell-cell interfaces makes this receptor highly important for the study of cellular regeneration and various types of disease.
-
ID gène
- 2043
-
NCBI Accession
- NM_001304536
-
Pathways
- Signalisation RTK
Antigène
-